Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circulating Tumor Cell Genome in Peripheral Blood From Hepatocellular Carcinoma Patients Under Radiotherapy

NCT02066974 is registered in ClinicalTrials.gov with China Medical University, China as lead sponsor.

NCT NCT02066974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02066974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circulating Tumor Cell Genome in Peripheral Blood From Hepatocellular Carcinoma Patients Under Radiotherapy
Lead sponsor
China Medical University, China
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2014
Completion date
February 29, 2016
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse effect of radiation therapy, circulating neoplastic cells, fatal outcome